TrialPanorama/TrialPanorama-database huggingface dataset:
Study 25877635 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 10
Genes: IL10
Study 25877635 — Predictive Biomarker (PRD): TNFSF10 mRNA
Genes: TNFSF10; APO2L; TRAIL
Study 25878729 — Predictive Biomarker (PRD): C1QTNF3 mRNA
Genes: C1QTNF3; CTRP3; UNQ753/PRO1484
Study 25880823 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 25881847 — Predictive Biomarker (PRD): NRM mRNA
Genes: NRM; NRM29; UNQ555/PRO1112
Study 25882434 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Neutrophil gelatinase-associated lipocalin
Genes: LCN2; HNL; NGAL
Study 25882434 — Surrogate Endpoint (SUR): Serum creatinine
Study 25882434 — Safety Biomarker (SAF): Interleukin 18
Genes: IL18; IGIF; IL1F4
Study 25884546 — Predictive Biomarker (PRD): CALD1 mRNA
Genes: CALD1; CAD; CDM
Study 25885289 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study 25885289 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 25885289 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 25885289 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Serum albumin
Genes: ALB; GIG20; GIG42; PRO0903; PRO1708; PRO2044; PRO2619; PRO2675; UNQ696/PRO1341
Study 25885799 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 25886275 — Predictive Biomarker (PRD): MVD mRNA
Genes: MVD; MPD
Study 25886410 — Surrogate Endpoint (SUR): Cervical intraepithelial neoplasia
Study 25887094 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 25887777 — Predictive Biomarker (PRD): Lymphocyte activation antigen CD30
Genes: TNFRSF8; CD30; D1S166E
Study 25887777 — Predictive Biomarker (PRD): FCGR3A mRNA
Genes: FCGR3A; CD16A; FCG3; FCGR3; IGFR3
Study 25888403 — Surrogate Endpoint (SUR): Blood pressure
Study 25888646 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 25888961 — Surrogate Endpoint (SUR): Blood pressure
Study 25889044 — Predictive Biomarker (PRD): DGAT1 mRNA
Genes: DGAT1; AGRP1; DGAT
Study 25889044 — Predictive Biomarker (PRD): LPL mRNA
Genes: LPL; LIPD
Study 25889044 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study 25889305 — Predictive Biomarker (PRD): PLA2G2A mRNA
Genes: PLA2G2A; PLA2B; PLA2L; RASF-A
Study 25889305 — Safety Biomarker (SAF): PLA2G2C mRNA
Genes: PLA2G2C
Study 25889305 — Predictive Biomarker (PRD): PLA2G2D mRNA
Genes: PLA2G2D; SPLASH
Study 25889305 — Predictive Biomarker (PRD): PLA2G2F mRNA
Genes: PLA2G2F
Study 25889305 — Predictive Biomarker (PRD): PLA2G4A mRNA
Genes: PLA2G4A; CPLA2; PLA2G4
Study 25889305 — Predictive Biomarker (PRD): PLA2G6 mRNA
Genes: PLA2G6; PLPLA9
Study 25889305 — Predictive Biomarker (PRD): PLA2G7 mRNA
Genes: PLA2G7; PAFAH
Study 25889498 — Pharmacodynamic Biomarker (PDY): Dipeptidyl peptidase 4
Genes: DPP4; ADCP2; CD26
Study 25890604 — Surrogate Endpoint (SUR): Blood pressure
Study 25890798 — Surrogate Endpoint (SUR): Forced vital capacity
Study 25891174 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study 25893247 — Predictive Biomarker (PRD): MB mRNA
Genes: MB
Study 25893603 — Predictive Biomarker (PRD): HNF1B mRNA
Genes: HNF1B; TCF2
Study 25894585 — Predictive Biomarker (PRD): Arginine vasopressin
Genes: AVP; ARVP; VP
Study 25895616 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study 25896390 — Predictive Biomarker (PRD): BTLA mRNA
Genes: BTLA
Study 25896390 — Predictive Biomarker (PRD): KLRK1 mRNA
Genes: KLRK1; D12S2489E; NKG2D
Study 25896390 — Predictive Biomarker (PRD): TNFRSF14 mRNA
Genes: TNFRSF14; HVEA; HVEM; UNQ329/PRO509
Study 25896390 — Safety Biomarker (SAF): Transforming growth factor beta 1
Genes: TGFB1; TGFB
Study 25896390 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study 25896421 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 25896421 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study 25896707 — Surrogate Endpoint (SUR): Serum creatinine
Study 25897014 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study 25897792 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 25899478 — Predictive Biomarker (PRD): Exhaled nitric oxide
Study 25899478 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Immunoglobulin E
Study 25899478 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 25899782 — Predictive Biomarker (PRD): PNP mRNA
Genes: PNP; NP
Study 25900182 — Predictive Biomarker (PRD): IGF1R mRNA
Genes: IGF1R
Study 25900182 — Predictive Biomarker (PRD): IGF1 mRNA
Genes: IGF1; IBP1
Study 25900275 — Predictive Biomarker (PRD): Apolipoprotein E
Genes: APOE
Study 25900467 — Predictive Biomarker (PRD): TSPAN31 mRNA
Genes: TSPAN31; SAS
Study 25901286 — Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): TNF related activation protein
Genes: CD40LG; CD40L; TNFSF5; TRAP
Study 25901286 — Predictive Biomarker (PRD): CD28 mRNA
Genes: CD28
Study 25902322 — Pharmacodynamic Biomarker (PDY): Transmembrane glycoprotein NMB
Genes: GPNMB; HGFIN; NMB; UNQ1725/PRO9925
Study 25903311 — Safety Biomarker (SAF): Cytochrome P450 2C19
Genes: CYP2C19
Study 25904635 — Predictive Biomarker (PRD): RAB5B mRNA
Genes: RAB5B
Study 25904635 — Predictive Biomarker (PRD): SUOX mRNA
Genes: SUOX
Study 25904635 — Predictive Biomarker (PRD): YAP1 mRNA
Genes: YAP1; YAP65
Study 25906326 — Surrogate Endpoint (SUR): Forced vital capacity
Study 25908766 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 25908927 — Safety Biomarker (SAF): Neutrophil to lymphocyte
Study 25909192 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 25912185 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 25914327 — Predictive Biomarker (PRD): IDE mRNA
Genes: IDE
Study 25915455 — Surrogate Endpoint (SUR): Blood pressure
Study 25915510 — Predictive Biomarker (PRD): PTPRC mRNA
Genes: PTPRC; CD45
Study 25915780 — Predictive Biomarker (PRD): CDKN1A mRNA
Genes: CDKN1A; CAP20; CDKN1; CIP1; MDA6; PIC1; SDI1; WAF1
Study 25917561 — Predictive Biomarker (PRD): VASP mRNA
Genes: VASP
Study 25918250 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 25918250 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 25919461 — Pharmacodynamic Biomarker (PDY): Fibroblast growth factor 23
Genes: FGF23; HYPF; UNQ3027/PRO9828
Study 25923090 — Predictive Biomarker (PRD): TPO mRNA
Genes: TPO
Study 25923090 — Safety Biomarker (SAF): Thyroid stimulating hormone
Study 25923549 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 25923731 — Surrogate Endpoint (SUR): Blood pressure
Study 25924874 — Predictive Biomarker (PRD): PRKACA mRNA
Genes: PRKACA; PKACA
Study 25924990 — Surrogate Endpoint (SUR): Blood pressure
Study 25925619 — Predictive Biomarker (PRD): CD79B mRNA
Genes: CD79B; B29; IGB
Study 25925673 — Predictive Biomarker (PRD): CDKN1B mRNA
Genes: CDKN1B; KIP1; p27
Study 25925673 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 25925673 — Predictive Biomarker (PRD): CCND1 mRNA
Genes: CCND1; BCL1; PRAD1
Study 25925673 — Predictive Biomarker (PRD): CCND1
Genes: U21B31
Study 25925673 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study 25926311 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 25926600 — Predictive Biomarker (PRD): PF4 mRNA
Genes: PF4; CXCL4; SCYB4
Study 25926858 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 25927528 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 25927528 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study 25927528 — Predictive Biomarker (PRD): UBC mRNA
Genes: UBC
Study 25928811 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 25929582 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study 25929922 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 25929922 — Predictive Biomarker (PRD): CD38 mRNA
Genes: CD38
Study 25931518 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study 25931518 — Predictive Biomarker (PRD): CDK5 mRNA
Genes: CDK5; CDKN5; PSSALRE
Study 25932660 — Predictive Biomarker (PRD): AGER mRNA
Genes: AGER; RAGE
Study 25932797 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 25932797 — Surrogate Endpoint (SUR): Blood pressure
Study 25933809 — Monitoring Biomarker (MOI): Carcinoembryonic antigen CEA
Genes: CEACAM5; CEA
Study 25933833 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study 25933833 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study 25934187 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Mitochondrial DNA
Study 25934475 — Predictive Biomarker (PRD): Liver iron
Study 25935582 — Predictive Biomarker (PRD): CYP19A1 mRNA
Genes: CYP19A1; ARO1; CYAR; CYP19
Study 25936321 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 25937263 — Predictive Biomarker (PRD): BRCA1 mRNA
Genes: BRCA1; RNF53
Study 25937426 — Predictive Biomarker (PRD): NPEPPS mRNA
Genes: NPEPPS; PSA
Study 25938519 — Predictive Biomarker (PRD): SOX5 mRNA
Genes: SOX5
Study 25938519 — Predictive Biomarker (PRD): NR4A3 mRNA
Genes: NR4A3; CHN; CSMF; MINOR; NOR1; TEC
Study 25938638 — Predictive Biomarker (PRD): RPE65 mRNA
Genes: RPE65
Study 25939704 — Surrogate Endpoint (SUR): Bone mineral density
Study 25939720 — Predictive Biomarker (PRD): PNPLA3 mRNA
Genes: PNPLA3; ADPN; C22orf20
Study 25942403 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study 25942403 — Surrogate Endpoint (SUR): Serum creatinine
Study 25942723 — Predictive Biomarker (PRD): IFNL3 mRNA
Genes: IFNL3; IL28B; IL28C; ZCYTO22
Study 25944628 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 25947565 — Pharmacodynamic Biomarker (PDY): Cyclin-dependent kinase 1
Genes: CDK1; CDC2; CDC28A; CDKN1; P34CDC2
Study 25948783 — Predictive Biomarker (PRD): HYLS1 mRNA
Genes: HYLS1; HLS
Study 25952086 — Predictive Biomarker (PRD): LAMB2 mRNA
Genes: LAMB2; LAMS
Study 25952795 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 25953829 — Pharmacodynamic Biomarker (PDY): Gastric inhibitory polypeptide
Genes: GIP
Study 25953829 — Pharmacodynamic Biomarker (PDY): Dipeptidyl peptidase 4
Genes: DPP4; ADCP2; CD26
Study 25954817 — Predictive Biomarker (PRD): PAM mRNA
Genes: PAM
Study 25955252 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Intercellular adhesion molecule 1
Genes: ICAM1
Study 25955319 — Predictive Biomarker (PRD): CYP3A4 mRNA
Genes: CYP3A4; CYP3A3
Study 25955319 — Predictive Biomarker (PRD): CYP3A5 mRNA
Genes: CYP3A5
Study 25955359 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study 25955359 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Hepatocyte growth factor
Genes: HGF; HPTA
Study 25955359 — Predictive Biomarker (PRD): SERPINF1 mRNA
Genes: SERPINF1; PEDF; PIG35
Study 25955359 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study 25955404 — Predictive Biomarker (PRD); Safety Biomarker (SAF): PSD mRNA
Genes: PSD; EFA6; EFA6A; KIAA2011; PSD1; TYL
Study 25956795 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study 25956918 — Surrogate Endpoint (SUR): Blood pressure
Study 25957377 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study 25957377 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study 25957391 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 25957497 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 25957999 — Predictive Biomarker (PRD): MCTS1 mRNA
Genes: MCTS1; MCT1
Study 25957999 — Predictive Biomarker (PRD): SLC16A4 mRNA
Genes: SLC16A4; MCT4; MCT5
Study 25959555 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Neutrophil gelatinase-associated lipocalin
Genes: LCN2; HNL; NGAL
Study 25962426 — Predictive Biomarker (PRD); Safety Biomarker (SAF): PIK3CA
Genes: PI3K
Study 25962439 — Safety Biomarker (SAF): DHFR
Genes: DHFR1
Study 25962717 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 25962717 — Predictive Biomarker (PRD): Proto-oncogene c-Met
Genes: MET
Study 25962728 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 25963019 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study 25963019 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 25963019 — Predictive Biomarker (PRD): NRAS mRNA
Genes: NRAS; HRAS1
Study 25963019 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study 25963299 — Predictive Biomarker (PRD): SDS mRNA
Genes: SDS; SDH
Study 25963299 — Predictive Biomarker (PRD): BMF mRNA
Genes: BMF
Study 25963299 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 25963299 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study 25963299 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 25963722 — Predictive Biomarker (PRD): SPR mRNA
Genes: SPR
Study 25964244 — Pharmacodynamic Biomarker (PDY): Gamma-Histone H2AX
Genes: H2AX; H2AFX
Study 25964296 — Predictive Biomarker (PRD): Leukocyte surface antigen Leu-16
Genes: MS4A1; CD20
Study 25964296 — Predictive Biomarker (PRD): CD55 mRNA
Genes: CD55; CR; DAF
Study 25964505 — Predictive Biomarker (PRD): ADRA2A mRNA
Genes: ADRA2A; ADRA2R; ADRAR
Study 25964599 — Predictive Biomarker (PRD): U2AF1 mRNA
Genes: U2AF1; U2AF35; U2AFBP; FP793
Study 25964599 — Predictive Biomarker (PRD): ZRSR2 mRNA
Genes: ZRSR2; U2AF1-RS2; U2AF1L2; U2AF1RS2; URP
Study 25966740 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study 25966740 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study 25967993 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 25968306 — Surrogate Endpoint (SUR): Serum testosterone
Study 25968622 — Predictive Biomarker (PRD): CS mRNA
Genes: CS
Study 25968826 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 25969833 — Surrogate Endpoint (SUR): Blood pressure
Study 25971886 — Predictive Biomarker (PRD): DMTN mRNA
Genes: DMTN; DMT; EPB49
Study 25972018 — Surrogate Endpoint (SUR): Blood pressure
Study 25976768 — Predictive Biomarker (PRD): MIP mRNA
Genes: MIP; AQP0
Study 25977266 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 25977463 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 25977463 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study 25977584 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study 25977584 — Predictive Biomarker (PRD): CASP9
Genes: MCH6; ICE-LAP6; APAF-3; PPP1R56
Study 25977882 — Predictive Biomarker (PRD): SSTR2 mRNA
Genes: SSTR2
Study 25977882 — Predictive Biomarker (PRD): IDH1 mRNA
Genes: IDH1; PICD
Study 25977882 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 25977884 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study 25979098 — Predictive Biomarker (PRD): BAG3 mRNA
Genes: BAG3; BIS
Study 25979109 — Predictive Biomarker (PRD): GUCY2C mRNA
Genes: GUCY2C; GUC2C; STAR
Study 25979109 — Predictive Biomarker (PRD): GUCA2A mRNA
Genes: GUCA2A; GUCA2
Study 25979109 — Safety Biomarker (SAF): Interleukin 1 alpha
Genes: IL1A; IL1F1
Study 25979109 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 1 beta
Genes: IL1B; IL1F2
Study 25979109 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 25979109 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Interferon gamma
Genes: IFNG
Study 25979109 — Predictive Biomarker (PRD): CDX2 mRNA
Genes: CDX2; CDX3
Study 25981169 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 25981814 — Predictive Biomarker (PRD): FGFR2 mRNA
Genes: FGFR2; BEK; KGFR; KSAM
Study 25981814 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study 25981814 — Predictive Biomarker (PRD): PDGFRB mRNA
Genes: PDGFRB; PDGFR; PDGFR1
Study 25981814 — Predictive Biomarker (PRD): KIT mRNA
Genes: KIT; SCFR
Study 25982012 — Predictive Biomarker (PRD): RET mRNA
Genes: RET; CDHF12; CDHR16; PTC; RET51
Study 25982012 — Predictive Biomarker (PRD): AKT2 mRNA
Genes: AKT2
Study 25982504 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Monitoring Biomarker (MOI): Vitamin B12
Study 25982653 — Surrogate Endpoint (SUR): Blood pressure
Study 25982652 — Surrogate Endpoint (SUR): Blood pressure
Study 25982654 — Surrogate Endpoint (SUR): Blood pressure
Study 25983041 — Predictive Biomarker (PRD): TMPRSS2 mRNA
Genes: TMPRSS2; PRSS10
Study 25983041 — Predictive Biomarker (PRD): Phosphatase and tensin homolog
Genes: PTEN; MMAC1; TEP1
Study 25985404 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 25985870 — Safety Biomarker (SAF): MTR
Genes: cblG
Study 25987775 — Monitoring Biomarker (MOI): HBV DNA
Study 25989829 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 25989829 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-C motif chemokine 2
Genes: CCL2; MCP1; SCYA2
Study 25989829 — Safety Biomarker (SAF): T-cell specific protein RANTES
Genes: CCL5; D17S136E; SCYA5
Study 25989829 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 25992307 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 25992639 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 25992656 — Surrogate Endpoint (SUR): Bone mineral density
Study 25994356 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 25994566 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 25995224 — Predictive Biomarker (PRD): CD28 mRNA
Genes: CD28
Study 25995224 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study 25998039 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 25998042 — Predictive Biomarker (PRD): Proto-oncogene c-Met
Genes: MET
Study 26000503 — Monitoring Biomarker (MOI): Cell-free DNA
Study 26002753 — Predictive Biomarker (PRD): KIT mRNA
Genes: KIT; SCFR
Study 26003997 — Surrogate Endpoint (SUR): Blood pressure
Study 26006067 — Predictive Biomarker (PRD): BRCA1 mRNA
Genes: BRCA1; RNF53
Study 26006067 — Predictive Biomarker (PRD): BRCA2 mRNA
Genes: BRCA2; FACD; FANCD1
Study 26006067 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Cellular tumor antigen p53
Genes: TP53; P53
Study 26006067 — Predictive Biomarker (PRD): CDK4 mRNA
Genes: CDK4
Study 26006067 — Predictive Biomarker (PRD): Homologous recombination deficiency
Study 26006114 — Predictive Biomarker (PRD): CYP2E1 mRNA
Genes: CYP2E1; CYP2E
Study 26009994 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study 26010298 — Predictive Biomarker (PRD): SIT1 mRNA
Genes: SIT1; SIT
Study 26016860 — Predictive Biomarker (PRD): SAT1 mRNA
Genes: SAT1; SAT
Study 26016860 — Predictive Biomarker (PRD): HEXIM2 mRNA
Genes: HEXIM2; L3
Study 26018350 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 26019869 — Predictive Biomarker (PRD): FHL5 mRNA
Genes: FHL5; ACT
Study 26020125 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study 26020762 — Predictive Biomarker (PRD): SI mRNA
Genes: SI
Study 26021444 — Predictive Biomarker (PRD): Thymidylate synthase 
Genes: TYMS; TS; OK/SW-cl.29
Study 26021713 — Predictive Biomarker (PRD): MSC mRNA
Genes: MSC; ABF1; BHLHA22
Study 26021713 — Predictive Biomarker (PRD): SCD mRNA
Genes: SCD; FADS5; SCD1; SCDOS
Study 26021713 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Interleukin 8
Genes: CXCL8; IL8
Study 26021713 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study 26021978 — Predictive Biomarker (PRD): PC mRNA
Genes: PC
Study 26024688 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 26025807 — Surrogate Endpoint (SUR): Serum bactericidal antibody
Study 26025965 — Predictive Biomarker (PRD); Safety Biomarker (SAF): PIK3CA
Genes: PI3K
Study 26025965 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 26025965 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study 26025965 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study 26026216 — Surrogate Endpoint (SUR): Blood pressure
Study 26026390 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study 26028668 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study 26028668 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 26028668 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 26028668 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study 26028965 — Predictive Biomarker (PRD): JAK2 mRNA
Genes: JAK2
Study 26030086 — Predictive Biomarker (PRD): PNP mRNA
Genes: PNP; NP
Study 26030086 — Predictive Biomarker (PRD): CFB mRNA
Genes: CFB; BF; BFD
Study 26030696 — Predictive Biomarker (PRD): HHIP mRNA
Genes: HHIP; HIP; UNQ5825/PRO19644